Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alsoKnownAs |
gptkb:saracatinib
|
| gptkbp:CASNumber |
379231-04-6
|
| gptkbp:chemicalClass |
quinazoline derivative
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
gptkb:AstraZeneca
|
| gptkbp:hasMolecularFormula |
C22H17ClFN5O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
ZD4522
|
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
Src kinase inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
gptkb:Src_family_kinases
|
| gptkbp:bfsParent |
gptkb:rosuvastatin
|
| gptkbp:bfsLayer |
6
|